Atlas Trials

Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient

Clinical trial NCT00002025 · COMPLETED

Trial details

NCT number
NCT00002025
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cytomegalovirus InfectionsCytomegalovirus RetinitisHIV Infections

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.